Program Overview:
A 5-meeting series designed to educate the multidisciplinary HCC care team on the latest advances in the diagnosis and treatment of HCC and BTC with immunotherapy and best practices for communicating with other team members and patients by providing access to specialists in academic centers to share best practices

Target Audience:
This educational activity is intended for medical oncologists, interventional oncologists/radiologists, hepatologists, pathologists, and allied health professionals (PAs, NPs, or nurses/nurse navigators, etc.) who are involved in the management of patients with liver cancer.

Upon completion of the activity, participants should be able to:

• Compare and contrast clinical profiles of immunotherapies for the treatment of advanced HCC and BTC
• Describe the results of key clinical trials investigating novel immunotherapy approaches for HCC
• Formulate a plan that considers patient-reported outcomes, such as physical functioning, symptom burden, psychological well-being, and social functioning
• Develop strategies for effective multidisciplinary communication and coordination

Faculty:
Adam Yopp, MD
Professor, Department of Surgery
Chief, Division of Surgical Oncology
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center
Dallas, TX

Amit Singal, MD – 6/20
Medical Director of the Liver Tumor Program
Clinical Chief of Hepatology
Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, TX

Anjana Pillai, MD – 6/17, 7/15
Associate Professor of Medicine
Associate Professor of Surgery
Co-Director, Living Donor Liver Transplant Program
Medical Director, Liver Tumor Program
Director, Transplant Hepatology Fellowship Program
UChicago Medicine
Chicago, IL

Joseph Franses, MD, PhD – 6/17, 7/15
Assistant Professor of Medicine
Hematology and Oncology
UChicago Medicine
Chicago, IL

Katie Kelley, MD
Professor of Clinical Medicine
Chair, Data and Safety Monitoring Committee, Helen Diller Family Comprehensive Cancer Center
Co-Director of Clinical Research, Division of Hematology and Oncology
University of California, San Francisco
San Francisco, CA

Osman Ahmed, MD – 6/17, 7/15
Associate Professor of Radiology
Interventional Radiology
UChicago Medicine
Chicago, IL

Mikin V. Patel, MD
Assistant Professor of Radiology
Interventional Radiology
Vascular and Interventional Radiology
UChicago Medicine
Chicago, IL

Planning Committee:
Adam Burgoyne, MD, PhD
Associate Clinical Professor
Department of Medicine
Division of Hematology/Oncology
University of California, San Diego
San Diego, CA

Amit Singal, MD
Medical Director of the Liver Tumor Program
Clinical Chief of Hepatology
Professor of Internal Medicine
UT Southwestern Medical Center
Dallas, TX

Anjana Pillai, MD
Associate Professor of Medicine
Associate Professor of Surgery
Co-Director, Living Donor Liver Transplant Program
Medical Director, Liver Tumor Program
Director, Transplant Hepatology Fellowship Program
UChicago Medicine
Chicago, IL

Isabel Newton, MD, PhD
Department of Radiology
Assistant Professor of Radiology
University of California, San Diego
San Diego, CA

Stacey Stein, MD
Associate Professor of Internal Medicine
Assistant Medical Director, Clinical Trials Office
Yale Medicine
New Haven, CT

There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the activity, and completing the posttest and evaluation form.

Credit Fulfillment:
If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation, your certificate will be available for download.

This activity is provided by The France Foundation.

In support of improving patient care, this activity has been planned and implemented by The France Foundation. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT DESIGNATION

Physicians
The France Foundation designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
The France Foundation designates this activity for a maximum of 5.0 contact hours.

Physician Assistants
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for a maximum of 5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

All other healthcare professionals completing this course will be issued a statement of participation.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by an educational grant from AstraZeneca.

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.